Read the full article here.
This content was originally published by BusinessLIVE. Original publishers retain all rights. It appears here for a limited time before automated archiving. By BusinessLIVE
Russia licensed the two-shot vaccine for domestic use in August and before any data had been published or a large-scale trial begun